The highest dose of Aurion Biotech’s cell therapy, the main component of which recently received approval in Japan, has ...

When asked what visitors can expect, Griffith promises an engaging and interactive experience. “People are welcome to visit ...

Sep. 9, 2024 — Scientists developed a highly promising gene therapy to treat glaucoma -- a debilitating eye condition that can lead to complete vision loss, and which affects around 80 million ...

From reprogrammed stem cells to next-generation gene editing, 2024 has seen some incredible developments with the potential to become new treatments.

A Pennsylvania boy was told he had a learning disability. Vision screening missed the real problem ...

A Durham biotechnology firm is partnering with a Japanese company to advance a gene therapy that has shown promise in ...

Aurion Biotech said its cell therapy for treating the cornea improved vision at the highest dose, which it plans to further ...

Vision is something many people take for granted. Many people don’t think twice about how different their lives would been if ...

VisiRose, a company formed in collaboration with Provectus Biopharmaceuticals and the University of Miami Miller School of ...

As a child, Brenden Koenig saw double and didn't see items' boundaries. Thanks to therapy, he's now doing what he loves: ...

According to the company, its Phase 1/2 CLARA trial of AURN001 for corneal edema demonstrated significant dose-dependent ...